Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefixime vs Penicillin G for Early Syphilis
NCT04958122Phase 3Recruiting
- Sponsor
- University of Southern California
- Start
- Jun 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cefixime in syphilis (2 arms), sponsored by University of Southern California. Primary endpoint: Response to treatment at 6 months. Started Jun 2021; status: recruiting.
02
Drugs
cefixime
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT04958122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04958122.